Showing results (331-340 of 550) with videos related to
Sort By:
Pageof 55
Kidney International|January 18, 2017
Patients receiving frequent hemodialysis have better health-related quality of life compared to patients receiving conventional hemodialysisAmit X Garg, Rita S Suri, Paul Eggers, et al.Addictive Behaviors Reports|February 22, 2024
Cigarette and ENDS dual use longitudinal transitions among adults in the Population Assessment of Tobacco and Health (PATH) Study, Waves 4-5 (2016-2019)Eva Sharma, Katarzyna Zebrak, Kristin Lauten, et al.The Lancet. Diabetes & Endocrinology|April 25, 2018
Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trialsSrinivasan Beddhu, Tom Greene, Robert Boucher, et al.Journal of the American Society of Nephrology : JASN|January 7, 2011
Acute kidney injury in older adultsSharon Anderson, Basil Eldadah, Jeffrey B Halter, et al.Kidney International|June 18, 2004
Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO StudyMark Unruh, Robert Benz, Tom Greene, et al.Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 10, 2013
Chronic interferon-α decreases dopamine 2 receptor binding and striatal dopamine release in association with anhedonia-like behavior in nonhuman primatesJennifer C Felger, Jiyoung Mun, Heather L Kimmel, et al.Nature Reviews. Nephrology|October 6, 2019
Sex and the kidneys: current understanding and research opportunitiesC Noel Bairey Merz, Laura M Dember, Julie R Ingelfinger, et al.The American Journal of Drug and Alcohol Abuse|October 26, 2018
Neuropsychological functioning in opioid use disorder: A research synthesis and meta-analysisScott C Wollman, Alexander O Hauson, Matthew G Hall, et al.Urology|October 6, 2023
Epidemiology of Infantile Ureteropelvic Junction Obstruction in the USChyng-Wen Fwu, Julia S Barthold, Susan R Mendley, et al.Kidney International Reports|August 1, 2017
<i>APOL1</i> renal-risk variants do not associate with incident cardiovascular disease or mortality in the Systolic Blood Pressure Intervention TrialBarry I Freedman, Michael V Rocco, Jeffrey T Bates, et al.Pageof 55